Silent Reflux and Sleep: What Actually Works

Your baby isn’t spitting up. So why are they waking every 45 minutes, arching their back, making a wet gurgling sound when laid flat, and refusing the breast or bottle after a few minutes?

That’s the trap of silent reflux. No visible evidence. Just a baby in pain, and parents who’ve been told “they seem fine” because nothing’s coming out.

Here’s what’s actually happening, and what the research says about fixing it.

What Silent Reflux Is (And Isn’t)

Gastroesophageal reflux disease (GERD) in infants happens when stomach acid travels up the oesophagus. In classic reflux, it makes it all the way out — you see it, you clean it up. In silent reflux (sometimes called laryngopharyngeal reflux or LPR), the acid comes up but gets swallowed back down before it exits.

No mess. But the acid still burns the oesophageal lining on the way up and back down. Twice the contact, no visible sign.

The oesophagus of a young infant is short — typically 8–10 cm from stomach to throat. A reflux episode doesn’t have far to travel to cause significant irritation.

Signs You’re Dealing With Silent Reflux

These symptoms, especially in combination, point toward silent reflux:

• Back-arching (Sandifer syndrome posture) — instinctive extension of the neck and back to try to straighten the oesophagus and relieve burning
• Wet or gurgly breathing when flat — acid pooling at the back of the throat
• Hiccups, especially after feeds — the lower oesophageal sphincter (LOS) triggering
• Feed aversion — baby starts feeding hungrily then pulls off, cries, refuses to continue. Eating causes pain.
• Worse sleep when flat — gravity is no longer helping contain stomach contents
• Excessive swallowing — clearing acid from the throat
• Hoarse cry — acid irritating the larynx

None of these symptoms are diagnostic alone. But if your baby has four or more, and they’re worse after feeds and when flat, the clinical picture is clear enough to act on.

Positioning: What the Evidence Actually Shows

This is the most common advice given. It’s also mostly wrong.

Elevated head-of-bed: Intuitive, but doesn’t hold up. The 2022 AAP safe sleep guidelines explicitly state that elevating the head of the crib is ineffective in reducing GER and is not recommended. A biomechanical analysis found that infants cannot be placed at a 30-degree incline without sliding down — and that sliding positions can compromise respiration. Two separate studies (reference: AAP 2022, Pediatrics 150(1)) found no benefit.

Semi-inclined positions (bouncers, car seats for sleep): The AAP position is clear: there is evidence that semi-inclined positions can make reflux worse by increasing abdominal pressure. Car seats are for cars.

Left-lateral positioning when awake and supervised: For an older infant who can be observed, there is some evidence that left-lateral positioning (stomach on the left side) slows gastric emptying in the right direction and reduces reflux episodes. But this is supervised, awake positioning only — not for sleep.

The flat-on-back rule stands. Safe sleep means back, flat, on a firm surface. There is no reflux evidence strong enough to override SIDS risk. The good news: most babies do adapt. The priority is treating the reflux, not repositioning the baby.

Practical move: Keep baby upright for 20–30 minutes after feeds. Not in a bouncer — held upright against your chest or shoulder. This is low-risk and consistently recommended across guidelines, though RCT evidence is limited.

Thickeners: The Best Non-Pharmacological Option

If positioning doesn’t resolve the symptoms, feed thickening is the next step with the strongest evidence base.

How they work: Thickeners increase the viscosity of milk, making it physically harder for stomach contents to travel back up the oesophagus. This reduces the frequency and volume of reflux episodes.

What the evidence shows: A 2017 Cochrane review (Kwok et al., Cochrane Database Syst Rev) found moderate-quality evidence that feed thickeners reduce visible regurgitation by approximately 2 episodes per day (mean difference −1.97, 95% CI: −2.32 to −1.61). That’s a meaningful reduction in symptom burden.

Important caveat: thickeners reduce visible symptoms. They don’t change pH-probe measured acid reflux. The acid still goes up — it just doesn’t come back out as visibly. This is why thickeners work better for classic reflux than for silent reflux. They may still help by reducing the volume of refluxate that reaches the oesophagus.

Locust Bean Gum (Johannesbroodpitmeel / Carob Bean Gum)

This is the standard thickening agent in European anti-reflux (AR) formulas such as Aptamil AR, Nutrilon Anti-Reflux, and others. It’s a naturally derived galactomannan polysaccharide.

Advantages over rice cereal:

• Pre-mixed in formula — no preparation required
• Doesn’t significantly alter caloric density when used at recommended concentrations
• Liquid in the bottle, thickens on contact with stomach acid (important: it doesn’t thicken until it reaches the stomach)
• Evidence from multiple RCTs showing reduction in regurgitation frequency

Safety note: Locust bean gum is generally considered safe for term infants. It is NOT recommended for preterm infants or infants in NICU settings due to a theoretical increased risk of necrotising enterocolitis (NEC), though evidence is limited.

Rice Cereal

Older approach. Thickens immediately in the bottle (unlike locust bean gum), which can clog nipples and require larger holes. Increases caloric density, which can lead to overfeeding and paradoxically worsen reflux through distension. Multiple professional bodies have moved away from recommending rice cereal thickening as a first-line approach.

Commercial Thickeners (Carobel, Nestlé Resource ThickenUp)

Carobel (locust bean gum powder) can be added to breastmilk — the pre-mixed AR formulas can’t. For breastfeeding parents, this is the thickener route. Evidence: comparable to AR formula for reducing visible regurgitation.

If you’re breastfeeding: Thickening breastmilk with locust bean gum powder (Carobel) is possible. Mix separately, add to bottle of expressed milk. It’s an imperfect workaround, but it’s the best available option short of medication.

Gaviscon Infant: Weaker Than You’ve Been Told

Gaviscon Infant (sodium alginate + magnesium alginate) forms a gel raft on the surface of stomach contents, creating a physical barrier that’s meant to prevent acid from refluxing up.

It sounds convincing. The evidence is much less so.

Del Buono 2005 (PMC1720405) is the key study to know. Twenty infants with clinically suspected GOR underwent 24-hour combined pH and intraluminal impedance monitoring. Each received six random administrations of Gaviscon Infant or placebo in a double-blind crossover design.

Results:

• Reflux events per hour: not significantly different (1.58 Gaviscon vs 1.68 placebo)
• Acid reflux events per hour: not significantly different (0.26 vs 0.43)
• Total acid clearance time: not significantly different
• Total reflux duration: not significantly different
• Reflux height: marginally but significantly lower with Gaviscon (66.6% vs 77.3% of oesophageal length, p < 0.05)

Read that again: the only statistically significant difference was how high the reflux traveled up the oesophagus. Not how often it happened, not how long acid contact lasted, not how much acid cleared. Just height.

Is reduced reflux height clinically meaningful? Maybe slightly — if acid reaches the throat and larynx, it causes more irritation than if it stays in the lower oesophagus. But this is a weak effect in a 20-infant study.

Earlier Buts et al. 1987 (PMID 3032640) found Gaviscon significantly reduced all pH-monitoring variables (Euler-Byrne index, total reflux time, number of episodes) compared to placebo in 10 infants, with reductions of 35–61% in acid reflux measures. This contradicts Del Buono 2005 directly. The Buts study used an older, less sensitive measurement technique (24h pH probe only, no impedance monitoring). Del Buono’s use of combined impedance/pH measurement is considered more accurate.

Bottom line on Gaviscon Infant: It may reduce reflux height slightly. It probably doesn’t meaningfully reduce the frequency or duration of reflux events. A 20-infant trial is underpowered to detect anything except large effects, and the large effects weren’t there.

This doesn’t mean you shouldn’t try it — for some babies it does seem to help, possibly through mechanisms not well captured by pH/impedance monitoring, or simply through the placebo effect on parental reporting. But go in with accurate expectations.

Gaviscon Infant in breastfed babies: Needs to be given as a powder dissolved in a small amount of water after feeding. More cumbersome than formula use. Some parents give up on compliance for this reason.

When Non-Pharmacological Isn’t Enough: The Medication Pathway

If you’ve done 2–3 weeks of feed thickening, consistent upright positioning post-feeds, and symptoms are still severe, it’s time to escalate.

Signs that non-pharmacological management isn’t working:

• Weight gain is faltering (falling across centile lines)
• Baby is taking significantly less milk due to feed aversion
• Sleep deprivation is extreme and sustained (every 30–45 minutes around the clock)
• Visible signs of oesophageal irritation: blood-tinged spit-up, coffee-ground-coloured vomit (these need urgent attention)
• Recurrent chest infections or unexplained apnea episodes (possible aspiration)

The medication route:

Omeprazole (a proton pump inhibitor) is the most evidence-supported pharmacological option for infant GERD. It reduces acid production, meaning less acid in the stomach to reflux. Typical dosing is 0.5–1 mg/kg/day. It requires a prescription.

Note: Despite widespread use, RCT evidence for PPIs in infants is more limited than you’d expect, and there’s ongoing debate about overuse. A 2009 RCT (Davidson 2009) found omeprazole was no better than placebo for crying in irritable infants — but that study didn’t specifically select infants with confirmed acid reflux. In infants with confirmed GERD via pH-impedance testing, PPIs do reduce acid exposure measurably.

Ranitidine (H2 blocker): Was commonly used but withdrawn in many countries due to NDMA contamination concerns. Some H2 blockers remain available (famotidine, cimetidine) but are less commonly used for infants now.

What to ask for: pH-impedance testing to confirm acid reflux before committing to long-term medication. Not always accessible, but it’s the only way to know whether acid is actually the problem.

What to Try: In Order

First: 20–30 minutes upright after every feed. Smaller, more frequent feeds (reduces gastric distension). These cost nothing and have no downside.

Second: Switch to an anti-reflux formula (locust bean gum-thickened) if formula feeding, or try Carobel powder added to expressed breastmilk. Do this consistently for 2 weeks before judging efficacy.

Third: Add Gaviscon Infant if thickening alone isn’t enough. Use for 2 weeks. Manage expectations — the evidence for additional benefit over thickening alone is thin.

If none of the above is working after 3–4 weeks, or if weight gain is suffering: This is when medication becomes the appropriate next step.

The natural history matters here too: most infant reflux, including silent reflux, resolves substantially by 12–18 months as the lower oesophageal sphincter matures and the infant spends more time upright. You’re managing symptoms through a window, not treating a permanent condition.

---

Key studies referenced: Del Buono et al. 2005 (PMC1720405); AAP Safe Sleep Guidelines 2022 (Pediatrics 150:1); Kwok et al. 2017 Cochrane Review on feed thickeners; Buts et al. 1987 (PMID 3032640).